Sign in

CIK 0001137883

  • Non-accelerated filer
  • Smaller reporting company

BRAINSTORM CELL THERAPEUTICS INC.

Sign in to watch
Ticker
BCLI
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
207273918
Phone
+1 201-488-0460
Business address
1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
Former names
BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Grant or award COO and Chief Medical Officer acquired 35,885 shares (grant or award)
  3. 4 Grant or award Director acquired 3,882 shares (grant or award)
  4. 4 Grant or award Director acquired 12,000 shares (grant or award)
  5. 4 Grant or award Director acquired 2,000 shares (grant or award)
  6. 4 Grant or award Director acquired 2,000 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award COO and Chief Medical Officer acquired 35,885 shares (grant or award)
  10. 4 Grant or award Chief Executive Officer acquired 31,185 shares (grant or award)
  11. 4 Grant or award Director acquired 12,000 shares (grant or award)
  12. 4 Grant or award Director acquired 4,216 shares (grant or award)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award Director acquired 6,666 shares (grant or award)
  16. 4 Derivatives Options or other derivatives
  17. 4 Grant or award Director acquired 2,000 shares (grant or award)
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 4 Shares withheld for taxes EVP, CFO and Treasurer gave up 25,000 shares (to pay taxes)

Page 4 of 17 · 329 filings